Michael Jos. Campbell - 18 May 2023 Form 4 Insider Report for INVO Bioscience, Inc. (IVF)

Role
Chief Operating Officer, Director
Signature
/s/ Michael Jos. Campbell
Issuer symbol
IVF
Transactions as of
18 May 2023
Net transactions value
$0
Form type
4
Filing time
22 May 2023, 19:56:07 UTC
Previous filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INVO Stock Option (right to buy) Award $0 +83,000 $0.000000 83,000 18 May 2023 Common Stock 83,000 $0.3680 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in twelve equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.